Altinoz, M. A. Et Al. 2018. From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo. CLINICAL NEUROLOGY AND NEUROSURGERY , vol.173 , 20-30.

Altinoz, M. A., Nalbantoglu, J., ÖZPINAR, A., Ozcan, M. E., Del Maestro, R. F., & Elmaci, I., (2018). From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo. CLINICAL NEUROLOGY AND NEUROSURGERY , vol.173, 20-30.

Altinoz, Meric Et Al. "From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo," CLINICAL NEUROLOGY AND NEUROSURGERY , vol.173, 20-30, 2018

Altinoz, Meric A. Et Al. "From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo." CLINICAL NEUROLOGY AND NEUROSURGERY , vol.173, pp.20-30, 2018

Altinoz, M. A. Et Al. (2018) . "From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo." CLINICAL NEUROLOGY AND NEUROSURGERY , vol.173, pp.20-30.

@article{article, author={Meric A. Altinoz Et Al. }, title={From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo}, journal={CLINICAL NEUROLOGY AND NEUROSURGERY}, year=2018, pages={20-30} }